Home Cart Sign in  
Chemical Structure| 163252-36-6 Chemical Structure| 163252-36-6

Structure of Clevudine
CAS No.: 163252-36-6

Chemical Structure| 163252-36-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Clevudine is an antiviral agent that used to treat hepatitis B.

Synonyms: L-FMAU; Levovir

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Clevudine

CAS No. :163252-36-6
Formula : C10H13FN2O5
M.W : 260.22
SMILES Code : O=C1NC(C(C)=CN1[C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)=O
Synonyms :
L-FMAU; Levovir
MDL No. :MFCD00935785
InChI Key :GBBJCSTXCAQSSJ-XQXXSGGOSA-N
Pubchem ID :73115

Safety of Clevudine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P280-P305+P351+P338-P310

Related Pathways of Clevudine

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00362700 Hepatitis B PHASE2 TERMINATED 2025-10-05 Korea University Guro Hospital... More >>, Seoul, Guro-gu, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-Gu, Korea, Republic of|Yongdong Severance Hospital, Dogok-dong, Kangnam-gu, Seoul, Korea, Republic of|Samsung Medical Center, Ilwon-dong, Songpa-gu, Seoul, Korea, Republic of|Ehwa Womans University Mokdong Hospital, Mok-dong, Yangcheon-gu, Seoul, Korea, Republic of|Seoul Asan Medical Center, Pungnap-dong, Kangnam-gu, Seoul, Korea, Republic of|Asan Medical Center, Pungnab2-dong, Songpa-Gu, Seoul, Korea, Republic of Less <<
NCT00313261 Hepatitis B PHASE2 TERMINATED 2025-02-05 Korea University Guro Hospital... More >>, Guro-dong, Guro-ku, Seoul, Korea, Republic of|Seoul National University, Yeongeon-dong, Jongno-Gu, Seoul, Korea, Republic of|Yongdong Severance Hospital, Dogok-dong, Kangnam-Gu, Seoul, Korea, Republic of|Samsung Medical Center, Ilwon-dong, Kangnam-Gu, Seoul, Korea, Republic of|Asan Medical Center, Pungnab2-dong, Songpa-Gu, Seoul, Korea, Republic of|Ewha Womans University Hospital, Mok-dong, Yangchon-Gu, Seoul, Korea, Republic of|St. Mary's Hospital, Youido, Yougdungpo-Gu, Seoul, Korea, Republic of Less <<
NCT00558818 Chronic Hepatitis B PHASE4 COMPLETED 2025-09-11 KoreaUniversity Guro Hospital,... More >> Seoul, Korea, Republic of Less <<
NCT01264094 Chronic Hepatitis B PHASE4 TERMINATED 2025-06-15 Gangnam Severance Hospital, Se... More >>oul, Korea, Republic of Less <<
NCT00362635 Hepatitis B PHASE3 COMPLETED - Alice Ho Miu Ling Nethersole H... More >>ospital, Tai Po, New Territories, Hong Kong|Queen Mary Hospital, Road, Hong Kong Less <<
NCT00558493 Chronic Hepatitis B PHASE4 COMPLETED - Youngnam University Medical Ce... More >>nter, Daegu, Korea, Republic of Less <<
NCT00313274 Hepatitis B PHASE3 TERMINATED 2025-12-04 St. Mercy's Hospital, Bupyoung... More >>-dong, Bupyoung-gu, Incheon, Korea, Republic of|Kangbuk Samsung Hospital, Pyoung-dong, Chongro-gu, Seoul, Korea, Republic of|Keimyumg University Dongsan Medical Center, Jung-gu, Daegu, Korea, Republic of|Chonnam National University Hospital, Hak-1-dong, Dong-gu, Gwangju-si, Korea, Republic of|Korea University Guro Hospital, Seoul City, Guro-gu, Korea, Republic of|Wonkwang University Hospital, Iksan-City, Jeonbuk, Korea, Republic of|Chonbuk National University Hospital, Jeonju-city, Jeonbuk, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-Gu, Korea, Republic of|Inha University Hospital, Sinhung-dong, Jung-gu, Incheon, Korea, Republic of|Yongdong Severance Hospital, Dogok-dong, Kangnam-gu, Seoul, Korea, Republic of|Seoul Asan Medical Center, Pungnap-dong, Kangnam-gu, Seoul, Korea, Republic of|National Cancer Center, Ilsan-gu, Kyounggi-do, Korea, Republic of|St. Holly Family Mary's Hospital, Puch'onae, Kyounggi-do, Korea, Republic of|Pochon CHA University Hospital, Seongnam-gu, Kyounggi-do, Korea, Republic of|Yeungnam University Medical Center, Dae myoung-dong, Nam-gu, Taegu, Korea, Republic of|Gil Medical Center, Incheon, Namdong-Gu, Korea, Republic of|Nowon Eulji Hospital, Hagye 1-dong, Nowon-gu, Seoul, Korea, Republic of|St. Vincent's Hospital, Ji-dong, Paldal-gu, Suwon, Korea, Republic of|Pusan Paik Hospital, Gaegeum-dong, Pusan, Korea, Republic of|Pusan National University Hospital, Ami-dong, Seo-gu, Pusan, Korea, Republic of|Kosin Medical Center, Amnam-dong, Seo-gu, Pusan, Korea, Republic of|KangNam St. Mary's Hospital, Banpo-dong, Seocho-gu, Seoul, Korea, Republic of|Severance Hospital, Shinchon- dong, Seodaemun-gu, Seoul, Korea, Republic of|Seoul Paik Hospital, Jeo-dong, Seoul, Korea, Republic of|Samsung Medical Center, Ilwon-dong, Songpa-gu, Seoul, Korea, Republic of|Korea University Anam Hospital, Anam-dong, Sungbuk-ku, Seoul, Korea, Republic of|Ehwa Womans University Mokdong Hospital, Mokdong, Yangcheon-gu, Seoul, Korea, Republic of|Kangnam Sacred Heart Hospital, Daelim-dong, Yongdeungpo-gu, Seoul, Korea, Republic of|Soon Chun Hyang University Hospital, Hannam-dong, Yongsan-gu, Seoul, Korea, Republic of|St. Mary's Hospital, Seoul, Yungdungpo-Gu, Korea, Republic of Less <<
NCT00362505 Hepatitis B PHASE3 TERMINATED 2025-03-06 Chungnam National University H... More >>ospital, Daesa-dong, Jung-gu, Daechon, Korea, Republic of|Keimyumg University Dongsan Medical Center, Jung-gu,, Daegu, Korea, Republic of|Kyungpook National University Medical Hospital, Jung-gu, Daegu, Korea, Republic of|Korea University Guro Hospital, Seoul, Guro-gu, Korea, Republic of|Chonnam National University Hospital, Hak-1-dong, Dong-gu, Gwangju-si, Korea, Republic of|St. Mercy's Hospital, Bupyoung-dong, Bupyoung-gu, Incheon, Korea, Republic of|Inha University Hospital, Sinhung-dong, Jung-gu, Incheon, Korea, Republic of|Wonkwang University Hospital, Iksan-City, Jeonbuk, Korea, Republic of|Chonbuk National University Hospital, Jeonju-city, Jeonbuk, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-Gu, Korea, Republic of|National Cancer Center, Ilsan-gu, Kyounggi-do, Korea, Republic of|St. Holly Family Mary's Hospital, Puch'un, Kyounggi-do, Korea, Republic of|Pochon CHA University Hospital, Seongnam-gu, Kyounggi-do, Korea, Republic of|Gil Medical Center, Incheon, Namdong-Gu, Korea, Republic of|Pusan National University Hospital, Ami-dong, Seo-gu, Pusan, Korea, Republic of|Kosin Medical Center, Amnam-dong, Seo-gu, Pusan, Korea, Republic of|Pusan Paik Hospital, Gaegeum-dong, Pusan, Korea, Republic of|Korea University Anam Hospital, Anam-dong, Sungbuk-ku, Seoul, Korea, Republic of|KangNam St. Mary's Hospital, Banpo-dong, Seocho-gu, Seoul, Korea, Republic of|Kangnam Sacred Heart Hospital, Daelim-dong, Yongdeungpo-gu, Seoul, Korea, Republic of|Yongdong Severance Hospital, Dogok-dong, Kangnam-gu, Seoul, Korea, Republic of|Korea Cancer Center Hospital, Gongneung-dong, Nowon-gu, Seoul, Korea, Republic of|Soon Chun Hyang University Hospital, Hannam-dong, Yongsan-gu, Seoul, Korea, Republic of|Samsung Medical Center, Ilwon-dong, Songpa-gu, Seoul, Korea, Republic of|Seoul Paik Hospital, Jeo-dong, Seoul, Korea, Republic of|Ehwa Womans University Mokdong Hospital, Mok-dong, Yangcheon-gu, Seoul, Korea, Republic of|Seoul Asan Medical Center, Pungnap-dong, Kangnam-gu, Seoul, Korea, Republic of|Kangbuk Samsung Hospital, Pyoung-dong, Chongro-gu,, Seoul, Korea, Republic of|Severance Hospital, Shinchon- dong, Seodaemun-gu, Seoul, Korea, Republic of|St. Vincent's Hospital, Ji-dong,, Paldal-gu, Suwon, Korea, Republic of|Yeungnam University Medical Center, Daemyoung-dong, Nam-gu, Taegu, Korea, Republic of|St. Mary's Hospital, Seoul, Yungdungpo-Gu, Korea, Republic of Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.84mL

0.77mL

0.38mL

19.21mL

3.84mL

1.92mL

38.43mL

7.69mL

3.84mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

[1]Hu R, Li L, et al. Behavior of thymidylate kinase toward monophosphate metabolites and its role in the metabolism of 1-(2'-deoxy-2'-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (Clevudine) and 2',3'-didehydro-2',3'-dideoxythymidine in cells. Antimicrob Agents Chemother. 2005 May;49(5):2044-9.

[2]Chong Y, Chu CK. Understanding the unique mechanism of L-FMAU (clevudine) against hepatitis B virus: molecular dynamics studies. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3459-62.

[3]Asselah T, Lada O, Moucari R, Marcellin P. Clevudine: a promising therapy for the treatment of chronic hepatitis B. Expert Opin Investig Drugs. 2008 Dec;17(12):1963-74

[4]Korba BE, Furman PA, Otto MJ. Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo. Expert Rev Anti Infect Ther. 2006 Aug;4(4):549-61

[5]Jang JH, Kim JW, Jeong SH, Myung HJ, Kim HS, Park YS, Lee SH, Hwang JH, Kim N, Lee DH. Clevudine for chronic hepatitis B: antiviral response, predictors of response, and development of myopathy. J Viral Hepat. 2011 Feb;18(2):84-90

[6]Yoo BC, Kim JH, Kim TH, Koh KC, Um SH, Kim YS, Lee KS, Han BH, Chon CY, Han JY, Ryu SH, Kim HC, Byun KS, Hwang SG, Kim BI, Cho M, Yoo K, Lee HJ, Hwang JS, Kim YS, Lee YS, Choi SK, Lee YJ, Yang JM, Park JW, Lee MS, Kim DG, Chung YH, Cho SH, Choi JY, Kweon YO, Lee HY, Jeong SH, Yoo HW, Lee HS. Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression. Hepatology. 2007 Oct;46(4):1041-8

 

Historical Records

Categories